| Advantages | They preserve essential disease characteristics, such as genetic mutations and protein expression profiles, positioning them as reliable models for bile duct cancer research. |
| Species | Human |
| Product Type | Tissue-derived Organoid |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Bile duct |
| Disease | Cholangiocarcinoma |
| Organoid Characterization | Cholangiocarcinoma organoids display high pathological similarity to tumor tissues, with expression of key markers including CK7, CEA, and CA19-9. |
| Applications | Their ability to sustain tumor heterogeneity and model the tumor microenvironment (TME) supports comprehensive studies of disease progression and treatment outcomes. These physiologically relevant organoids are critical tools for advancing precision medicine and accelerating the development of targeted therapies for cholangiocarcinoma. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.